Xylem (XYL) Tops Q1 EPS by 10c; raises Guidance

Xylem (NYSE: XYL) reported Q1 EPS of $0.72, $0.10 better than the analyst estimate of $0.62. Revenue for the quarter came in at $1.45 billion versus the consensus estimate of $1.35 billion.

GUIDANCE:

Xylem sees FY2023 EPS of $3.15-$3.35, versus the consensus of $3.22.

For earnings history and earnings-related data on Xylem (XYL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c